A A Email Print Share

Dr. Cavanuagh Chosen To Participate In AACP Leadership Program

A School of Pharmacy faculty member has been chosen to participate in a newly established American Association of Colleges of Pharmacy (AACP) leadership program. Nominated by Dean Bricker, Dr. Jane Cavanaugh, Associate Professor of Pharmacology, will be a member of the inaugural class of AACP Catalyst: Accelerating Research Leadership.

The year-long program will require Dr. Cavanaugh to attend three sessions–in Alexandria, VA, Long Beach, CA, and Rockville, MD–where she and other participants will receive group and individual coaching from experienced research leaders on shaping the future of her own research and that of Duquesne University School of Pharmacy.

Program participants will be given the opportunity to build a network of research funders and collaborators to expand their research and grow their national reputation for research. In addition, they will acquire approaches for sustaining high impact research programs throughout changes in social, economic and political climates. Dr. Cavanaugh will also work closely with her chosen research mentor, Dr. Paula Witt-Enderby, to establish her role as a research leader and help shape the research landscape at Duquesne University using skills learned throughout the year.

Dr. Cavanaugh received a PhD from the Pennsylvania State University College of Medicine in the Department of Pharmacology. She conducted her postdoctoral training at the University of Washington, where she investigated the role of intracellular signaling pathways in neuronal cell death and survival. She received a Career Award (K-01) from the National Institute on Aging to conduct research focused on the role of these pathways in neurodegenerative diseases and cell death that occurs with normal brain aging and internal funding from the Faculty Development Fund grant from Duquesne University to study breast cancer and aging. She is currently funded by an R15 from the NCI to investigate novel small molecule inhibitors of MEK5-ERK5 for the treatment of breast cancer.

Duquesne University

Founded in 1878, Duquesne is consistently ranked among the nation's top Catholic universities for its award-winning faculty and tradition of academic excellence. Duquesne, a campus of nearly 9,500 graduate and undergraduate students, has been nationally recognized for its academic programs, community service and commitment to sustainability. Follow Duquesne University on Facebook, Twitter and Instagram.
www.duq.edu